Insulin-glucagon interaction in controlling splanchnic glucose production in normal man. 1977

J D Bomboy, and S B Lewis, and B C Sinclair-Smith, and W W Lacy, and J E Liljenquist

The interaction of glucagon and insulin in controlling hepatic glucose production in man has been inferred from studies of immunoreactive glucagon and insulin. This study directly examines the interaction of glucagon and insulin in controlling net splanching glucose production (NSGP) in eight normal men. Glucagon was infused iv at 5 ng/kg/min for 15 min and resultant arterial glucagon levels (1.3 X 10(-10) M) did not exceed the physiologic portal range. In four normal men NSGP increased 2.3-fold by 5 min and remained elevated for 15 min. There was no change in arterial insulin concentration. To study the effect of exogenous insulin on this glucagon-induced increase in NSGP, insulin was infused at 10 mU/kg/min in four normal men to achieve arterial immunoreactive insulin concentrations of 1500 muU/ml (1 X 10(-8) M). Blood glucose was stabilized by glucose infusions. During insulin and glucose administration, NSGP was suppressed and net splanchnic glucose uptake occurred. After 40 min of insulin and glucose pretreatment, a 5 ng/kg/min glucagon infusion resulted in no increase in NSGP (arterial insulin: glucagon molar ratio of approximately 100). In two subjects the glucagon infusion rate was then increased to 15 ng/kg/min (arterial insulin: glucagon molar ratio of approximately 33), resulting in stimulation of NSGP. These studies provide evidence that insulin in high concentration can suppress glucagon-stimulated NSGP in normal man.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001916 Brachial Artery The continuation of the axillary artery; it branches into the radial and ulnar arteries. Arteries, Brachial,Artery, Brachial,Brachial Arteries
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006503 Hepatic Veins Veins which drain the liver. Hepatic Vein,Vein, Hepatic,Veins, Hepatic

Related Publications

J D Bomboy, and S B Lewis, and B C Sinclair-Smith, and W W Lacy, and J E Liljenquist
October 1979, Diabetologia,
J D Bomboy, and S B Lewis, and B C Sinclair-Smith, and W W Lacy, and J E Liljenquist
November 1950, The Journal of clinical investigation,
J D Bomboy, and S B Lewis, and B C Sinclair-Smith, and W W Lacy, and J E Liljenquist
January 1988, International journal of clinical pharmacology, therapy, and toxicology,
J D Bomboy, and S B Lewis, and B C Sinclair-Smith, and W W Lacy, and J E Liljenquist
June 1978, Metabolism: clinical and experimental,
J D Bomboy, and S B Lewis, and B C Sinclair-Smith, and W W Lacy, and J E Liljenquist
September 1976, The Journal of clinical investigation,
J D Bomboy, and S B Lewis, and B C Sinclair-Smith, and W W Lacy, and J E Liljenquist
June 1972, New Istanbul contribution to clinical science,
J D Bomboy, and S B Lewis, and B C Sinclair-Smith, and W W Lacy, and J E Liljenquist
January 1979, The Journal of clinical endocrinology and metabolism,
J D Bomboy, and S B Lewis, and B C Sinclair-Smith, and W W Lacy, and J E Liljenquist
December 1977, Acta endocrinologica,
J D Bomboy, and S B Lewis, and B C Sinclair-Smith, and W W Lacy, and J E Liljenquist
February 1976, Diabetes,
J D Bomboy, and S B Lewis, and B C Sinclair-Smith, and W W Lacy, and J E Liljenquist
January 1973, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
Copied contents to your clipboard!